Literature DB >> 27571781

Serum markers of inflammation and oxidative stress in sarcopenia.

Busra Can1, Ozgur Kara2, Muhammet Cemal Kizilarslanoglu2, Gunes Arik2, Gozde Sengul Aycicek2, Fatih Sumer2, Ramazan Civelek3, Canan Demirtas4, Zekeriya Ulger2.   

Abstract

BACKGROUND: Sarcopenia is a geriatric syndrome characterized by the presence of low muscle mass and function. Possible mechanisms underlying sarcopenia include oxidative stress and elevation of inflammatory cytokines. AIMS: The aim of the study was to evaluate the relationship between sarcopenia and biomarkers that may be involved in its pathogenesis and hence early detection.
METHODS: A total of 72 patients (36 sarcopenic and 36 non-sarcopenic) were included in the study. An experienced geriatric team applied comprehensive geriatric assessment to all patients. Anthropometric measures, gait speed and handgrip strength were recorded. Bioelectrical impedance analysis was used to assess skeletal muscle mass. In addition to routine clinical laboratory tests, serum adiponectin, thioredoxin-1 and pentraxin-3 levels were measured. Sarcopenia was defined according to the European Working Group on Sarcopenia in older Adults as the presence of low muscle mass and low muscle function or muscle performance.
RESULTS: Sarcopenic patients were more likely to be functionally dependent and had lower scores on comprehensive geriatric assessment tools. Erythrocyte sedimentation rate (ESR) and C-reactive protein levels were significantly higher in the sarcopenic group. There was no significant difference in serum levels of thioredoxin-1 and pentraxin-3. Sarcopenic patients had lower levels of hemoglobin, albumin, total protein, calcium, triglycerides, uric acid and adiponectin (p < 0.05). Hypertension and body mass index were inversely correlated with sarcopenia whereas ESR was positively correlated. DISCUSSION AND
CONCLUSION: The present study demonstrated an association of sarcopenia with inflammatory markers CRP, ESR and adiponectin. Long-term prospective studies are warranted to confirm the relationship between markers oxidative stress and age related muscle decline.

Entities:  

Keywords:  Adiponectin; Inflammation; Oxidative stress; Pentraxin-3; Sarcopenia; Thioredoxin-1

Mesh:

Substances:

Year:  2016        PMID: 27571781     DOI: 10.1007/s40520-016-0626-2

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  41 in total

1.  Longitudinal assessment of the impact of higher body mass index on cancer-related fatigue in patients with breast cancer receiving chemotherapy.

Authors:  Julia E Inglis; Michelle C Janelsins; Eva Culakova; Karen M Mustian; Po-Ju Lin; Ian R Kleckner; Luke J Peppone
Journal:  Support Care Cancer       Date:  2019-07-02       Impact factor: 3.603

2.  Better muscle strength with healthy eating.

Authors:  Yahya Pasdar; Shima Moradi; Mehdi Moradinazar; Behrooz Hamzeh; Farid Najafi
Journal:  Eat Weight Disord       Date:  2020-02-10       Impact factor: 4.652

Review 3.  The Pathological Links between Adiposity and the Carpal Tunnel Syndrome.

Authors:  Marina Ruxandra Otelea; Roxana Nartea; Florina Georgeta Popescu; Anatoli Covaleov; Brindusa Ilinca Mitoiu; Adriana Sarah Nica
Journal:  Curr Issues Mol Biol       Date:  2022-06-08       Impact factor: 2.976

4.  Causal Relationship of Genetically Predicted Serum Micronutrients Levels With Sarcopenia: A Mendelian Randomization Study.

Authors:  Tingting Sha; Wei Li; Hongyi He; Jing Wu; Yilun Wang; Hui Li
Journal:  Front Nutr       Date:  2022-06-22

5.  The relationship between sarcopenia detected in newly diagnosed colorectal cancer patients and FGF21, irisin and CRP levels.

Authors:  Utku Oflazoglu; Sevinc Caglar; Huriye Erbak Yılmaz; Hülya Tas Önal; Umut Varol; Tarik Salman; Yasar Yildiz; Sinan Unal; Zeynep Gulsum Guc; Yuksel Kucukzeybek; Ahmet Alacacioglu; Mustafa Oktay Tarhan
Journal:  Eur Geriatr Med       Date:  2022-03-11       Impact factor: 3.269

6.  The association of sarcopenia, telomere length, and mortality: data from the NHANES 1999-2002.

Authors:  Peter L Rippberger; Rebecca T Emeny; Todd A Mackenzie; Stephen J Bartels; John A Batsis
Journal:  Eur J Clin Nutr       Date:  2017-12-14       Impact factor: 4.016

Review 7.  Experimental Models of Sarcopenia: Bridging Molecular Mechanism and Therapeutic Strategy.

Authors:  Sakulrat Mankhong; Sujin Kim; Sohee Moon; Hyo-Bum Kwak; Dong-Ho Park; Ju-Hee Kang
Journal:  Cells       Date:  2020-06-02       Impact factor: 6.600

8.  Relationship between Oral Hypofunction and Sarcopenia in Community-Dwelling Older Adults: The Otassha Study.

Authors:  Yoshihiro Kugimiya; Masanori Iwasaki; Yuki Ohara; Keiko Motokawa; Ayako Edahiro; Maki Shirobe; Yutaka Watanabe; Shuichi Obuchi; Hisashi Kawai; Yoshinori Fujiwara; Kazushige Ihara; Hunkyung Kim; Takayuki Ueda; Hirohiko Hirano
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

9.  Sarcopenia and serum biomarkers of oxidative stress after a 6-month physical activity intervention in women with metastatic breast cancer: results from the ABLE feasibility trial.

Authors:  Vincent Pialoux; Béatrice Fervers; Lidia Delrieu; Agnès Martin; Marina Touillaud; Olivia Pérol; Magali Morelle; Olivia Febvey-Combes; Damien Freyssenet; Christine Friedenreich; Armelle Dufresne; Thomas Bachelot; Pierre-Etienne Heudel; Olivier Trédan; Hugo Crochet; Amine Bouhamama; Frank Pilleul
Journal:  Breast Cancer Res Treat       Date:  2021-05-19       Impact factor: 4.872

10.  Identifying Frail-Related Biomarkers among Community-Dwelling Older Adults in Japan: A Research Example from the Japanese Gerontological Evaluation Study.

Authors:  N Cable; A Hiyoshi; N Kondo; J Aida; H Sjöqvist; K Kondo
Journal:  Biomed Res Int       Date:  2018-01-22       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.